Inflammopharmacology is the official publication of the Gastrointestinal Section of the International Union of Basic and Clinical Pharmacology (IUPHAR) and the Hungarian Experimental and Clinical Pharmacology Society (HECPS). Inflammopharmacology publishes papers on all aspects of inflammation and its pharmacological control emphasizing comparisons of (a) different inflammatory states, and (b) the actions, therapeutic efficacy and safety of drugs employed in the treatment of inflammatory conditions. The comparative aspects of the types of inflammatory conditions include gastrointestinal disease (e.g. ulcerative colitis, Crohn's disease), parasitic diseases, toxicological manifestations of the effects of drugs and environmental agents, arthritic conditions, and inflammatory effects of injury or aging on skeletal muscle. The journal has seven main interest areas:

Drug-Disease Interactions - Conditional Pharmacology - i.e. where the condition (disease or stress state) influences the therapeutic response and side (adverse) effects from anti-inflammatory drugs. Mechanisms of drug-disease and drug disease interactions and the role of different stress states
Rheumatology - particular emphasis on methods of measurement of clinical response effects of new agents, adverse effects from anti-rheumatic drugs
Gastroenterology - with particular emphasis on animal and human models, mechanisms of mucosal inflammation and ulceration and effects of novel and established anti-ulcer, anti-inflammatory agents, or antiparasitic agents
Neuro-Inflammation and Pain - model systems, pharmacology of new analgesic agents and mechanisms of neuro-inflammation and pain
Novel drugs, natural products and nutraceuticals - and their effects on inflammatory processes, especially where there are indications of novel modes action compared with conventional drugs e.g. NSAIDs
Muscle-immune interactions during inflammation: mechanisms of inflammation and anti-inflammatory actions of therapeutic agents on skeletal muscle under conditions of aging or injury.
Safety and efficacy of Non-prescription (OTC) and prescription NSAIDs and Analgesics

Editor-in-Chief
Kim D. Rainsford
Biomedical Research Centre
Sheffield Hallam University
Howard Street
Sheffield, S1 1WB
United Kingdom
and
Faculty of Health and Medical Sciences
Adelaide Medical School
North Terrace, Adelaide
South Australia
Australia, 5005
E-mail: editor@inflammopharmacology.com
Deputy Editors
Omar M.E. Abdel-Salam
National Research Center, Cairo, Egypt

Phillip J. Berry
Diabetes Medical Team, MSD, Hoddeston, England, UK

Lyndsey E. Collins-Praino
Discipline of Anatomy and Pathology
University of Adelaide
Adelaide, SA, Australia

Klára Gyires
Semmelweis University
Department of Pharmacology and Pharmacotherapy
Budapest, Hungary

Parto S. Khansari
Stony Brook School of Pharmacy and Pharmaceutical Sciences
Stony Brook, NY, USA

Walter F. Kean
Department of Medicine
McMaster University 
Hamilton, Ontario, Canada

David R. Haynes
Discipline of Anatomy and Pathology
University of Adelaide
Adelaide, SA, Australia

Rajan Radhakrishnan
College of Medicine
Mohammed Bin Rashid University of Medicine and Health Sciences
Dubai, United Arab Emirates
Eugene Roscioli
Royal Adelaide Hospital
Department of Thoracic Medicine
Adelaide, SA, Australia

Beatá Sperlágh
Hungarian Academy of Sciences
Budapest, Hungary

Luis Vitetta
Medlab Clinical Ltd. and The University of Sydney Medical School
Alexandria, NSW, Australia
Section Editors
Ageing, Muscle and Exercise
Kathryn H. Myburgh and Carine Smith
Department of Physiological Sciences, Stellenbosch University, South Africa
Biologics
Drug-Disease Interactions - Conditional Pharmacology
Michael C. Powanda 
M/P Biomedical Consultants LLC, Mill Valley, CA, USA
Michael W. Whitehouse
School of Medicine, Griffith University, Brisbane, Qld., Australia

Gastroenterology
Klára Gyires, Semmelweis University, Budapest, Hungary

General Pharmacology
HECPS Representative
Beatá Sperlágh
Hungarian Academy of Sciences, Budapest, Hungary
Inflammation in Dementias
Joel S. Ross, RHNanopharmaceutics LLC, Monmouth Beach, NJ, USA
Inflammatory Aspects of Metabolic Diseases and Diabetes
Linh Ho
Department of Pharmaceutical and Biomedical Sciences, California Northstate University, University College of Pharmacy, Sacramento, CA, USA
Inflammatory Mechanisms
Diane Cooper
The William Harvey Research Institute, Barts and The Queen Mary's School of Medicine and Dentistry, London, UK
Inflammatory Respiratory Diseases
Eugene Roscioli
Royal Adelaide Hospital, Department of Thoracic Medicine, Adelaide, SA, Australia

Natural Products
Ian Cock
School of Natural Sciences, Griffith University, Brisbane, Qld., Australia

Neuroinflammation
Parto S. Khansari
Stony Brook School of Pharmacy and Pharmaceutical Sciences, Stony Brook, NY, USA

New Drug Developments
Stefan A. Laufer
Pharmaceutical Institute, University of Tübingen, Tübingen, Germany
Ian M. Hunneyball
Evotec Inc, Abingdon, Oxon, United Kingdom

Burkhard Hinz
Institute for Pharmacology and Toxicology, University Medicine Rostock, Rostock, Germany


Oral and Maxillofacial Pharmacology
Thomas Dietrich
Birmingham Dental Hospital & University of Birmingham, Birmingham, United Kingdom
Pharmacoepidemiology and OTC Drugs
Phillip J. Berry
Diabetes Medical Team, MSD, Hoddeston, England, UK

Pharmaceutics and Topical Delivery of Analgesics
Michael Roberts
The University of Queensland
Diamantina Institute, School of Medicine, Brisbane, Qld., Australia

Probiotics and Microbiome Studies in Gastroenterology
Ingvar Bjarnason
King's College Hospital and Medical School, London, United Kingdom
Luis Vitetta
Medlab Clinical Ltd. and The University of Sydney Medical School, Alexandria, NSW, Australia


Editorial Consultants
Brian A. Callingham, Cambridge, UK
Richard H. Hunt, Hamilton, ON, Canada
Walter F. Kean, Hamilton, ON, Canada
Michael P. Seed, London, UK
Jagdish N. Sharma, Safat, Kuwait
Sandor Szabo, Los Angeles, CA, USA
Michael W. Whitehouse, Brisbane, Qld., Australia
Editorial Board
Omar M.E. Abdel-Salam, Cairo, Egypt
Tetsuo Arakawa, Osaka, Japan
Samir S. Ayoub, London, UK
Ingvar Bjarnason, London, UK
Joanne Bowen, Adelaide, SA, Australia
Jonas Kure Buer, Oslo, Norway
Melissa Cantley, Adelaide, SA, Australia
Cho Hin Cho, Hong Kong, China
Nigel Farrow, Adelaide, SA, Australia
Ludmila P. Filaretova, St.Petersburg, Russia
Leo R. Fitzpatrick, Elk Grove, CA, USA
Isaac Ginsburg, Jerusalem, Israel
Rodrigo Guabiraba, Nouzilly, France
Colin Kean, Hamilton, ON, Cananda
Julie Keeble, London, UK
Chak-Sing Lau, Hong Kong, China
Thomas Leung, Hong Kong, China
Xiaowen Liang, Brisbane, Qld., Australia
Leonard M. Lichtenberger, Houston, TX, USA
Xin Liu, Brisbane, Qld., Australia
Hugo F. Miranda, Santiago, Chile
Nicholas Moore, Bordeaux, France
Andrew J.K. Östör,Malvern, Vic, Australia
Michael C. Powanda, Mill Valley, CA, USA
Rajan Radhakrishnan, Dubai, United Arab Emirates
Saravanan Subramanian, Omaha, NE, USA
Murtaza M. Tambuwala, Ulster, UK
Cijo George Vazhappilly, Ras Al Khaimah, UAE